CoChat
Sign Up
Cited by 172Connective tissue disorders researchDermatological and Skeletal DisordersGenomics and Rare Diseases

A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders

Open access
Gensure, Robert C., Mäkitie, Outi, Barclay, Catherine, Chan, Catherine, DePalma, Steven R., Bastepe, Murat, Abuzahra, Hilal, Couper, Richard +6 more·2005·Journal of Clinical Investigation
DOI 10.1172/jci22760
Open this paper in CoChat — free accountOpen PDF

Abstract

Infantile cortical hyperostosis (Caffey disease) is characterized by spontaneous episodes of subperiosteal new bone formation along 1 or more bones commencing within the first 5 months of life. A genome-wide screen for genetic linkage in a large family with an autosomal dominant form of Caffey disease (ADC) revealed a locus on chromosome 17q21 (LOD score, 6.78). Affected individuals and obligate carriers were heterozygous for a missense mutation (3040Ctwo head right arrowT) in exon 41 of the gene encoding the alpha1(I) chain of type I collagen (COL1A1), altering residue 836 (R836C) in the triple-helical domain of this chain. The same mutation was identified in affected members of 2 unrelated, smaller families with ADC, but not in 2 prenatal cases and not in more than 300 chromosomes from healthy individuals. Fibroblast cultures from an affected individual produced abnormal disulfide-bonded dimeric alpha1(I) chains. Dermal collagen fibrils of the same individual were larger, more variable in shape and size, and less densely packed than those in control samples. Individuals bearing the mutation, whether they had experienced an episode of cortical hyperostosis or not, had joint hyperlaxity, hyperextensible skin, and inguinal hernias resembling symptoms of a mild form of Ehlers-Danlos syndrome type III. These findings extend the spectrum of COL1A1-related diseases to include a hyperostotic disorder.

Integrity signals

Registry

Crossref · 10.1172/jci22760

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • COL1A1 c.3040C>T, p.(Arg1014Cys) is associated with autosomal dominant Caffey disease.

    “c.3040C>T,p.(Arg1014Cys) is associated with autosomal dominant Caffey disease [Gensure et al., 2005]”

    From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Gensure et al., 2005

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Gensure, R. C., Mäkitie, O., Barclay, C., Chan, C., DePalma, S. R., Bastepe, M., Abuzahra, H., Couper, R., Mundlos, S., Sillence, D., Ala Kokko, L., Seidman, J. G., Cole, W. G., & Jüppner, H.
Affiliations
  • Harvard University (US)
  • Helsinki University Hospital (FI)
  • Hospital for Sick Children (CA)
  • Howard Hughes Medical Institute (US)
  • Women's and Children's Hospital (AU)
  • Max Planck Institute for Molecular Genetics (DE)
  • Children's Hospital at Westmead (AU)
Corresponding author
Jüppner, Harald
ORCID
Venue
Journal of Clinical Investigation
Publisher
American Society for Clinical Investigation
Published
2005-05-02
Volume
115
Issue
5
Pages
1250-1257
ISSN
0021-9738 (ISSN-L)
DOI
10.1172/jci22760
OpenAlex
W2162444478
Cited by
172
References
56
Citations by year
2026: 5 · 2025: 11 · 2024: 15 · 2023: 5 · 2022: 3 · 2021: 9 · 2020: 5 · 2019: 10 · 2018: 10 · 2017: 10 · 2016: 14 · 2015: 4 · 2014: 7 · 2013: 9 · 2012: 3
FWCI
5.05
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Funders
  • Massachusetts General Hospital
  • European Society for Paediatric Endocrinology
  • Novo Nordisk
  • Lastentautien Tutkimussäätiö
  • National Institutes of Health
  • U.S. Public Health Service (R01-46718-10)
  • Canadian Institutes of Health Research
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08 HD41512, K08HD041512)
  • Canadian Arthritis Network
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
infantile cortical hyperostosis, Caffey disease, COL1A1, autosomal dominant inheritance, chromosome 17q21, Ehlers-Danlos syndrome type III, joint hyperlaxity, inguinal hernia, genetic linkage
MeSH terms
Collagen Type I, alpha 1 Chain, Bone and Bones, Chromosome Mapping, Chromosomes, Human, Pair 17, Female, Fibula, Haplotypes, Humans, Hyperostosis, Cortical, Congenital, Infant, Male, Mutation, Pedigree, Radiography, Tibia, Dermis, Collagen Type I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review